{"ok":true,"trend":{"id":215438,"platform":"news","region":"global","key":"once described as obesity medicines for 'patients,' glp-1s are increasingly lifestyle drugs for 'customers'","title":"Once described as obesity medicines for 'patients,' GLP-1s are increasingly lifestyle drugs for 'customers'","url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNdGtlenYzdWdEM1VGQW5CeHFMeFFVTjlmOEJ1S0loZG5GVFBQTHU5NlpldzRQVENkbnpjalBrZW90R2tBUkNsTmZOd3dRUElGc3RUQlJ3Q3RHVkZJZVpnRGcwalE5QVhfMTF4dDgwZGVWU01PNUhpdzVzb1hoVWZ0R3FobkRzOU1aRVAtd0xETl9VYWFwOGc?oc=5","first_seen":"2026-09-28T09:10:46.558339Z","last_seen":"2026-09-28T11:54:47.455671Z","last_rank":4,"peak_rank":3,"last_volume":null,"peak_volume":0,"seen_count":3,"score":67.35,"category_hint":"medicine","section":"health","category":"medicine","summary":"GLP-1 drugs like Ozempic and Wegovy, originally framed as obesity treatments for patients with medical need, are increasingly being marketed and used as lifestyle products aimed at customers seeking cosmetic or wellness benefits. Observers note this shift raises questions about how the drugs are prescribed, who accesses them, and how the industry frames their purpose as demand widens beyond clinical obesity care.","why":"Rapid growth in GLP-1 use for cosmetic and lifestyle purposes is prompting debate over medical ethics and marketing.","tone":"neutral","entities":["Ozempic","Wegovy","Novo Nordisk","Eli Lilly"],"summarized_at":"2026-09-28T09:10:54.241263Z","meta":{"via":"scan","lang":"en","term":"medicine","source":"STAT","generic":0.07,"published":"Mon, 28 Sep 2026 08:31:16 GMT"},"nw":0.82,"promo":0.02,"kind":"news_event","importance":2.09,"hidden":false,"hide_reason":null,"judged_at":"2026-09-28T09:10:47.558412Z","title_en":"GLP-1 drugs shift from patient medicine to lifestyle product","section_name":"Health","category_name":"Medicine","timeline":[{"captured_at":"2026-09-28T09:10:46.558339Z","rank":4,"volume":null},{"captured_at":"2026-09-28T10:32:46.568837Z","rank":3,"volume":null},{"captured_at":"2026-09-28T11:54:47.455671Z","rank":4,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNdGtlenYzdWdEM1VGQW5CeHFMeFFVTjlmOEJ1S0loZG5GVFBQTHU5NlpldzRQVENkbnpjalBrZW90R2tBUkNsTmZOd3dRUElGc3RUQlJ3Q3RHVkZJZVpnRGcwalE5QVhfMTF4dDgwZGVWU01PNUhpdzVzb1hoVWZ0R3FobkRzOU1aRVAtd0xETl9VYWFwOGc?oc=5","author":"STAT","title":"Once described as obesity medicines for 'patients,' GLP-1s are increasingly lifestyle drugs for 'customers'","snippet":null,"posted_at":"2026-09-28T08:31:16Z","likes":null}],"elsewhere":[],"window":"7d"}}